Kolon Biotech, Inc. announced that it will issue 300,000 common shares at an issue price of KRW 18,540 for gross proceeds of KRW 5,562,000,000 on April 25, 2022. The transaction included participation returning investor Kolon Life Science Inc. to retain 100% stake in the company. The securities are issued through cash acquisition method.

The transaction was approved board of directors of the company. The transaction is expected to close on April 26, 2022.